
Molecule: ATEZOLIZUMAB
ChEMBL ID: CHEMBL3707227
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2016

Molecule: DURVALUMAB
ChEMBL ID: CHEMBL3301587
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2017

Molecule: AVELUMAB
ChEMBL ID: CHEMBL3833373
Mechanism of Action: OTHER
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2017

Molecule: SUGEMALIMAB
ChEMBL ID: CHEMBL4594535
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody

Molecule: BINTRAFUSP ALFA
ChEMBL ID: CHEMBL4298024
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Protein

Molecule: ENVAFOLIMAB
ChEMBL ID: CHEMBL4298006
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody

Molecule: PACMILIMAB
ChEMBL ID: CHEMBL4297563
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ERFONRILIMAB
ChEMBL ID: CHEMBL4650483
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: SOCAZOLIMAB
ChEMBL ID: CHEMBL4802221
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: SHR-1316
ChEMBL ID: CHEMBL4297828
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Unknown

Molecule: COSIBELIMAB
ChEMBL ID: CHEMBL4297729
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: INCB-086550
ChEMBL ID: CHEMBL4802209
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Unknown

Molecule: DANBURSTOTUG
ChEMBL ID: CHEMBL4650423
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
